Guangzhou Baiyunshan Valuation
| GU5 Stock | EUR 2.14 0.04 1.90% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Guangzhou Baiyunshan retains a regular Real Value of €2.44 per share. The prevalent price of the firm is €2.14. Our model calculates the value of Guangzhou Baiyunshan from evaluating the firm fundamentals such as return on asset of 0.0356, and Return On Equity of 0.13 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Guangzhou Baiyunshan's price fluctuation is risky at this time. Calculation of the real value of Guangzhou Baiyunshan is based on 3 months time horizon. Increasing Guangzhou Baiyunshan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Guangzhou stock is determined by what a typical buyer is willing to pay for full or partial control of Guangzhou Baiyunshan Pharmaceutical. Since Guangzhou Baiyunshan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guangzhou Stock. However, Guangzhou Baiyunshan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.14 | Real 2.44 | Hype 2.14 |
The real value of Guangzhou Stock, also known as its intrinsic value, is the underlying worth of Guangzhou Baiyunshan Company, which is reflected in its stock price. It is based on Guangzhou Baiyunshan's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Guangzhou Baiyunshan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Guangzhou Baiyunshan Pharmaceutical helps investors to forecast how Guangzhou stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guangzhou Baiyunshan more accurately as focusing exclusively on Guangzhou Baiyunshan's fundamentals will not take into account other important factors: Guangzhou Baiyunshan Total Value Analysis
Guangzhou Baiyunshan Pharmaceutical is currently estimated to have takeover price of 5.35 B with market capitalization of 6.7 B, debt of 752.81 M, and cash on hands of 21.69 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Guangzhou Baiyunshan fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.35 B | 6.7 B | 752.81 M | 21.69 B |
Guangzhou Baiyunshan Investor Information
About 34.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. Guangzhou Baiyunshan last dividend was issued on the 10th of June 2022. Based on the analysis of Guangzhou Baiyunshan's profitability, liquidity, and operating efficiency, Guangzhou Baiyunshan Pharmaceutical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Guangzhou Baiyunshan Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guangzhou Baiyunshan has an asset utilization ratio of 104.38 percent. This implies that the Company is making €1.04 for each dollar of assets. An increasing asset utilization means that Guangzhou Baiyunshan Pharmaceutical is more efficient with each dollar of assets it utilizes for everyday operations.Guangzhou Baiyunshan Ownership Allocation
Guangzhou Baiyunshan secures a total of 219.9 Million outstanding shares. 30% of Guangzhou Baiyunshan outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.Guangzhou Baiyunshan Profitability Analysis
The company reported the revenue of 69.01 B. Net Income was 3.72 B with profit before overhead, payroll, taxes, and interest of 13.19 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Guangzhou Baiyunshan's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Guangzhou Baiyunshan and how it compares across the competition.
About Guangzhou Baiyunshan Valuation
The stock valuation mechanism determines Guangzhou Baiyunshan's current worth on a weekly basis. Our valuation model uses a comparative analysis of Guangzhou Baiyunshan. We calculate exposure to Guangzhou Baiyunshan's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guangzhou Baiyunshan's related companies.Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. GUANG BAIY operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25168 people.
8 Steps to conduct Guangzhou Baiyunshan's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Guangzhou Baiyunshan's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Guangzhou Baiyunshan's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Guangzhou Baiyunshan's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Guangzhou Baiyunshan's revenue streams: Identify Guangzhou Baiyunshan's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Guangzhou Baiyunshan's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Guangzhou Baiyunshan's growth potential: Evaluate Guangzhou Baiyunshan's management, business model, and growth potential.
- Determine Guangzhou Baiyunshan's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Guangzhou Baiyunshan's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Guangzhou Stock analysis
When running Guangzhou Baiyunshan's price analysis, check to measure Guangzhou Baiyunshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Baiyunshan is operating at the current time. Most of Guangzhou Baiyunshan's value examination focuses on studying past and present price action to predict the probability of Guangzhou Baiyunshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Baiyunshan's price. Additionally, you may evaluate how the addition of Guangzhou Baiyunshan to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |